专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2010059828A1 AMNION DERIVED ADHERENT CELLS 审中-公开
标题翻译： AMNION衍生的附属细胞
公开(公告)号：WO2010059828A1
公开(公告)日：2010-05-27
申请号：PCT/US2009/065152
申请日：2009-11-19
申请人： ANTHROGENESIS CORPORATION , ABBOT, Stewart , EDINGER, James, W. , FRANCKI, Aleksandar , KAPLUNOVSKY, Aleksandr , JANKOVIC, Vladimir , LABAZZO, Kristen , LAW, Eric , PADLIYA, Neerav, D. , PAREDES, Jennifer , WANG, Jia-Lun
发明人： ABBOT, Stewart , EDINGER, James, W. , FRANCKI, Aleksandar , KAPLUNOVSKY, Aleksandr , JANKOVIC, Vladimir , LABAZZO, Kristen , LAW, Eric , PADLIYA, Neerav, D. , PAREDES, Jennifer , WANG, Jia-Lun
IPC分类号： C12N5/073
CPC分类号： A61K35/50 , A61K35/12 , C12N5/0605
摘要： Provided herein are novel angiogenic cells from amnion, referred to as amnion derived adherent cells, and populations of, and compositions comprising, such cells. Further provided herein are methods of obtaining such cells and methods of using the cells in the treatment of individuals.
摘要翻译：本文提供了来自羊膜的新型血管生成细胞，称为羊膜来源的贴壁细胞，以及包含这些细胞的群体和组合物。本文还提供了获得这样的细胞的方法和使用细胞治疗个体的方法。

2. 发明申请

WO2012083023A1 TREATMENT OF SPINAL CORD INJURY AND TRAUMATIC BRAIN INJURY USING AMNION DERIVED ADHERENT CELLS 审中-公开
标题翻译：使用粘膜衍生的附属细胞治疗脊髓损伤和TRAUMATIC脑损伤
公开(公告)号：WO2012083023A1
公开(公告)日：2012-06-21
申请号：PCT/US2011/065165
申请日：2011-12-15
申请人： ANTHROGENESIS CORPORATION , ABBOT, Stewart , EDINGER, James, W. , FRANCKI, Aleksandar , JANKOVIC, Vladimir , KAPLUNOVSKY, Aleksandr , LABAZZO, Kristen , LAW, Eric , LIANG, Bitao
发明人： ABBOT, Stewart , EDINGER, James, W. , FRANCKI, Aleksandar , JANKOVIC, Vladimir , KAPLUNOVSKY, Aleksandr , LABAZZO, Kristen , LAW, Eric , LIANG, Bitao
IPC分类号： A61K48/00 , C12N5/00
CPC分类号： C12N5/0605 , A61K35/50 , C12N5/0618 , C12N5/0636 , C12N5/0637 , C12N5/0639 , C12N5/0646 , C12N2502/025 , C12N2506/025
摘要： Provided herein are methods of treating spinal cord and traumatic brain injuries using cells from amnion, and populations of such cells, referred to herein as "amnion derived adherent cells" ("AMDACs").
摘要翻译：本文提供了使用羊膜细胞治疗脊髓和创伤性脑损伤的方法，以及这些细胞群，这里称为“羊膜来源的粘附细胞”（“AMDAC”）。

3. 发明申请

WO2011127117A1 ANGIOGENESIS USING PLACENTAL STEM CELLS 审中-公开
标题翻译：使用平面干细胞的血管生成
公开(公告)号：WO2011127117A1
公开(公告)日：2011-10-13
申请号：PCT/US2011/031335
申请日：2011-04-06
申请人： ANTHROGENESIS CORPORATION , ABBOT, Stewart , EDINGER, James , FRANCKI, Aleksander , HARIRI, Robert, J. , JANKOVIC, Vladimir , KAPLUNOVSKY, Aleksandr , LABAZZO, Kristen , LAW, Eric , PADLIYA, Neerav , PAREDES, Jennifer , WANG, Jia-Lun
发明人： ABBOT, Stewart , EDINGER, James , FRANCKI, Aleksander , HARIRI, Robert, J. , JANKOVIC, Vladimir , KAPLUNOVSKY, Aleksandr , LABAZZO, Kristen , LAW, Eric , PADLIYA, Neerav , PAREDES, Jennifer , WANG, Jia-Lun
IPC分类号： C12N5/073 , A61K35/50
CPC分类号： A61K35/50 , A61K9/0019 , A61K9/0085 , A61K35/28 , A61L27/3633 , A61L27/3683 , A61L27/3808 , A61L27/3834 , A61L27/3886 , A61L27/3895 , C12N5/0605 , A61K2300/00
摘要： Provided herein are methods of treating individuals having diseases or disorders of the circulatory system, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein, and populations of such placental cells. The invention also provides methods of angiogenesis using such cells or populations of cells comprising such cells.
摘要翻译：本文提供了使用胎盘细胞（例如本文所述的胎盘干细胞和胎盘多潜能细胞（PDAC））以及这些胎盘细胞群来治疗患有循环系统疾病或病症的个体的方法。本发明还提供了使用这种细胞或包含这种细胞的细胞群的血管生成方法。

4. 发明申请

WO2012083024A8 TREATMENT OF SPINAL CORD INJURY AND TRAUMATIC BRAIN INJURY USING PLACENTAL STEM CELLS 审中-公开
公开(公告)号：WO2012083024A8
公开(公告)日：2012-06-21
申请号：PCT/US2011/065170
申请日：2011-12-15
申请人： ANTHROGENESIS CORPORATION , ABBOT, Stewart , EDINGER, James, W. , FRANCKI, Aleksandar , JANKOVIC, Vladimir , KAPLUNOVSKY, Aleksandr , LABAZZO, Kristen , LAW, Eric , LIANG, Bitao , HARIRI, Robert, J.
发明人： ABBOT, Stewart , EDINGER, James, W. , FRANCKI, Aleksandar , JANKOVIC, Vladimir , KAPLUNOVSKY, Aleksandr , LABAZZO, Kristen , LAW, Eric , LIANG, Bitao , HARIRI, Robert, J.
IPC分类号： A61K48/00 , C12N5/00
摘要： Provided herein are methods of treatment of individuals having an injury to the central nervous system, such as a spinal cord injury or a traumatic brain injury, using placental stem cells and placental multipotent stem cells described herein, and populations of such placental cells.

5. 发明申请

WO2014152234A1 IMPROVED METHOD OF MAKING EXTRACELLULAR MATRIX COMPOSITIONS 审中-公开
标题翻译：制备细胞外基质组合物的改进方法
公开(公告)号：WO2014152234A1
公开(公告)日：2014-09-25
申请号：PCT/US2014/027102
申请日：2014-03-14
申请人： ANTHROGENESIS CORPORATION
发明人： BHATIA, Mohit, B. , KAPLUNOVSKY, Aleksandr , GUO, Xuan
IPC分类号： A61L27/56
CPC分类号： A61L27/3633 , A61L27/3662 , A61L27/3675 , A61L27/3687 , A61L27/3691 , A61L27/3834 , A61L2300/416 , A61L2430/10 , A61L2430/32 , A61L2430/38 , A61L2430/40
摘要： Provided herein are methods of producing extracellular matrix (ECM) that are superior to previously-described methods. Extracellular matrix (ECM) comprises protein that forms many structures in the body including tendons, ligaments, and sheets that support skin and internal organs. There remains a need in the art for ECM compositions that have improved cell attachment characteristics and methods of making such ECM compositions.
摘要翻译：本文提供的是产生优于前述方法的细胞外基质（ECM）的方法。细胞外基质（ECM）包括在体内形成许多结构的蛋白质，包括支持皮肤和内脏的肌腱，韧带和片。在本领域中仍然需要具有改善的细胞附着特性的ECM组合物和制备这种ECM组合物的方法。

6. 发明申请

WO2016033041A1 EXTRACELLULAR MATRIX COMPOSITIONS 审中-公开
标题翻译：细胞基质组成
公开(公告)号：WO2016033041A1
公开(公告)日：2016-03-03
申请号：PCT/US2015/046690
申请日：2015-08-25
申请人： ANTHROGENESIS CORPORATION
发明人： BHATIA, Mohit, B. , HERZBERG, Uri , KAPLUNOVSKY, Aleksandr , ZAKA, Raihana , YE, Qian
IPC分类号： A61K38/39
CPC分类号： A61K38/39 , A61K9/70 , A61K35/50 , A61K2300/00
摘要： Provided herein are placental extracellular matrix (ECM) compositions and methods of making the same. Also provided herein are uses of the placental ECM compositions provided herein. In one aspect, provided herein are extracellular matrix (ECM) compositions prepared using placental tissue, e.g., human placental tissue. In certain embodiments, the ECM compositions provided herein comprise about 30% to about 60% collagen and about 10% to about 35% elastin. In addition, such ECM compositions comprise (i) very low amounts of fibronectin (e.g., less than 0.1% fibronectin), e.g., as measured by ELISA; (ii) no or an undetectable amount of laminin, e.g., as measured by ELISA; and/or no or an undetectable amount of glycosaminoglycans, e.g., as measured by ELISA.
摘要翻译：本文提供胎盘细胞外基质（ECM）组合物及其制备方法。本文还提供了本文提供的胎盘ECM组合物的用途。在一个方面，本文提供了使用胎盘组织例如人胎盘组织制备的细胞外基质（ECM）组合物。在某些实施方案中，本文提供的ECM组合物包含约30％至约60％的胶原和约10％至约35％的弹性蛋白。此外，这种ECM组合物包含（i）非常低量的纤连蛋白（例如，小于0.1％的纤连蛋白），例如通过ELISA测量; （ii）无或不可检测量的层粘连蛋白，例如通过ELISA测量; 和/或没有或不可检测量的糖胺聚糖，例如通过ELISA测量。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式